FR3843M - Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice. - Google Patents

Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice.

Info

Publication number
FR3843M
FR3843M FR967704A FR967704A FR3843M FR 3843 M FR3843 M FR 3843M FR 967704 A FR967704 A FR 967704A FR 967704 A FR967704 A FR 967704A FR 3843 M FR3843 M FR 3843M
Authority
FR
France
Prior art keywords
antispasmodic
nitrogenous bases
vasodilator properties
new nitrogenous
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR967704A
Other languages
English (en)
Inventor
Etienne Szarvasi
Michel Bayssat
Louis Fontaine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
LIPHA Liyonnaise Industrielle Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS, LIPHA Liyonnaise Industrielle Pharmaceutique filed Critical LIPHA SAS
Priority to FR967704A priority Critical patent/FR3843M/fr
Application granted granted Critical
Publication of FR3843M publication Critical patent/FR3843M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/12—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR967704A 1964-03-17 1964-03-17 Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice. Expired FR3843M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR967704A FR3843M (fr) 1964-03-17 1964-03-17 Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR967704A FR3843M (fr) 1964-03-17 1964-03-17 Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice.

Publications (1)

Publication Number Publication Date
FR3843M true FR3843M (fr) 1966-01-17

Family

ID=8825728

Family Applications (1)

Application Number Title Priority Date Filing Date
FR967704A Expired FR3843M (fr) 1964-03-17 1964-03-17 Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice.

Country Status (1)

Country Link
FR (1) FR3843M (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505836A1 (fr) * 1981-05-14 1982-11-19 Sanofi Sa Citrate de naftidrofuryl et son application therapeutique
FR2508452A1 (fr) * 1981-06-30 1982-12-31 Sanofi Sa Isomeres du naftidrofuryl et procede pour leur preparation
FR2580502A1 (fr) * 1985-04-23 1986-10-24 Lipha Emploi du " naftidrofuryl " dans la preparation d'un medicament

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505836A1 (fr) * 1981-05-14 1982-11-19 Sanofi Sa Citrate de naftidrofuryl et son application therapeutique
EP0065446A1 (fr) * 1981-05-14 1982-11-24 Sanofi S.A. Citrate de naftidrofuryl et son application thérapeutique
FR2508452A1 (fr) * 1981-06-30 1982-12-31 Sanofi Sa Isomeres du naftidrofuryl et procede pour leur preparation
EP0069013A1 (fr) * 1981-06-30 1983-01-05 Elf Sanofi Isomères de naftidrofuryl et procédé pour leur préparation
FR2580502A1 (fr) * 1985-04-23 1986-10-24 Lipha Emploi du " naftidrofuryl " dans la preparation d'un medicament
US4652583A (en) * 1985-04-23 1987-03-24 Lipha, Lyonnaise Industrielle Pharmaceutique Use of naftidrofuryl to regenerate nerve fibers
EP0202986A3 (en) * 1985-04-23 1990-05-16 Lipha, Lyonnaise Industrielle Pharmaceutique Use of "naftidrofuryl" in the treatment of neuropathies

Similar Documents

Publication Publication Date Title
FR1508065A (fr) Phénoxy-alcanols, phénoxy-alcanals et leur obtention
OA01367A (fr) Nouvelles benzène-sulfonylurées et leur préparation.
FR3715M (fr) Antithermiques et antirhumatismaux améliorés.
FR1501363A (fr) N-acryl(polyoxyalcoyl)-oxazolidines et n-acryl(polyoxyalcoyl)-tétrahydro-1. 3-oxazines
FR1476551A (fr) Nouvelles styryléthanolamines
FR3843M (fr) Nouvelles bases azotées a propriétés antispasmodique et vasodilatatrice.
FR2428M (fr) Antispasmodique.
FR1484627A (fr) Nouvelles résines azotées thermostables
FR2590M (fr) Nouvelles associations antinévralgiques a tolérance améliorée.
FR2581M (fr) Nouvelles quinazolinones-(4) substituées a action centrale inhibitrice et anticonvulsivante.
FR1476558A (fr) Thiazolylthiobenzimidazoles et thiazolylsulfinylbenzimidazoles
OA01825A (fr) Nouvelles thiéno-benzothiazines substituées et leur préparation.
FR1530429A (fr) Nouvelles résines azotées thermostables
FR3756M (fr) Médicament vasodilatateur et hypotenseur a base de benzodioxanes.
CH432183A (de) Abläng- und Zentriermaschine
CH395791A (fr) Penna a sfera a punta retrattile, con pulsante comandabile in due tempi
FR1456909A (fr) Nouvelles résines sulfhydryles et leurs applications
FR1502926A (fr) Nouvelles résines azotées thermostables
FR2892M (fr) Substances a action immunisante et désensibilisante.
FR90402E (fr) Nouvelles résines azotées thermostables
FR1492776A (fr) Nouvelles résines azotées thermostables
FR3354M (fr) Nouveaux agents antispasmodiques et parasympatholytiques.
FR2554M (fr) Nouvelles testololactones et nouveaux acides secoandrostatriénoiques.
FR1488232A (fr) Sulfinylpyridines et sulfonylpyridines
FR1446538A (fr) Nouvelles imidazolines et leur obtention